Triple Jeopardy in Ageing: COVID-19, Co-morbidities and Inflamm-ageing

Rea, Irene Maeve; Alexander, H Denis

Covid-19 endangers lives, has disrupted normal life, changed the way medicine is practised and is likely to alter our world for the foreseeable future. Twenty months on since the presumptive first diagnosis of COVID-19 in China, more than two hundred million cases have been confirmed and more than four million people have died globally, with the figures rising daily. One of the most striking aspects of COVID-19 illness is the marked difference in individuals’ experiences of the disease. Some, most often younger groups, are asymptomatic, whereas others become severely ill with acute respiratory distress syndrome (ARDS), pneumonia or proceed to fatal organ disease. The highest death rates are in the older and oldest age groups and in people with co-morbidities such as diabetes, heart disease and obesity. Three major questions seem important to consider. What do we understand about changes in the immune system that might contribute to the older person’s risk of developing severe COVID-19? What factors contribute to the higher morbidity and mortality in older people with COVID-19? How could immunocompetence in the older and the frailest individuals and populations be supported and enhanced to give protection from serious COVID-19 illness?